GlassScriptPhysician profile
Varsha Kulkarni
NPI 1366528333
$18,700.35
in general payments reported to CMS, 2019-2025
46 companies · $6,437 in 2025
The $6,437 reported for 2025 was more than what 90% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,178 · 2020: $1,237 · 2021: $1,434 · 2022: $2,018 · 2023: $2,300 · 2024: $3,096 · 2025: $6,437.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,789 · Education: $3,057 · Travel and Lodging: $986.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,788.69 |
| Education | $3,057.48 |
| Travel and Lodging | $986.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,582.96 | 2022-2025 | |
| Glaxosmithkline, LLC. | $3,134.18 | 2019-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Astrazeneca Pharmaceuticals LP | $2,132.40 | 2019-2025 | Fasenra, Airsupra, Breztri |
| Pulmonx Corporation | $1,283.08 | 2020-2025 | Zephyr Endobronchial Valve, Chartis Catheter, Zephyr Delivery Catheter |
| Actelion Pharmaceuticals US, INC. | $904.22 | 2019-2025 | Opsumit, Uptravi, Opsynvi |
| Insmed, INC. | $812.72 | 2019-2025 | Arikayce, Brinsupri |
| Veran Medical Technologies, INC. | $720.36 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $617.86 | 2020-2025 | Dupixent |
| Genzyme Corporation | $554.49 | 2020-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $543.11 | 2019-2025 | Ofev, Jascayd, Stiolto Respimat |
| Merck Sharp & Dohme LLC | $512.12 | 2019-2025 | Winrevair |
| Bayer Healthcare Pharmaceuticals INC. | $360.32 | 2019-2024 | |
| Mylan Specialty L.P. | $339.95 | 2019-2024 | Yupelri |
| United Therapeutics Corporation | $313.48 | 2021-2025 | Tyvaso, Tyvaso |
| Inspire Medical Systems, INC. | $312.71 | 2022-2025 | Inspire |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $277.06 | 2024-2025 | Glassia, Cuvitru |
| Grifols USA, LLC | $263.26 | 2019-2025 | Xembify, Prolastin-C Liquid |
| Mallinckrodt Hospital Products INC. | $245.75 | 2020-2025 | Acthar |
| Shionogi INC | $174.07 | 2022-2024 | Fetroja |
| Amgen INC. | $163.55 | 2022-2024 | Tezspire |
| Viatris Specialty LLC | $156.33 | 2025 | Yupelri |
| Abbvie INC. | $133.52 | 2021-2024 | |
| Sunovion Pharmaceuticals INC. | $121.51 | 2019-2020 | |
| Avadel Cns Pharmaceuticals, LLC | $114.75 | 2025 | Lumryz |
| Melinta Therapeutics, LLC | $113.66 | 2022-2024 | Vabomere, Rezzayo |
| Genentech USA, INC. | $108.70 | 2019-2022 | |
| Jazz Pharmaceuticals INC. | $88.03 | 2024-2025 | |
| Baxter Healthcare | $81.58 | 2023-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Novartis Pharmaceuticals Corporation | $71.56 | 2019-2022 | |
| Verona Pharma, INC. | $58.53 | 2025 | Ohtuvayre |
| Sanofi-Aventis U.S. LLC | $57.48 | 2025 | |
| Ani Pharmaceuticals, INC. | $53.97 | 2023-2024 | Purified Cortrophin Gel |
| Gilead Sciences, INC. | $37.56 | 2019-2025 | Veklury |
| Tactile Systems Technology INC | $33.87 | 2025 | Nimbl, Flexitouch Plus |
| Teva Pharmaceuticals USA, INC. | $29.24 | 2021 | |
| Advanced Respiratory, INC | $27.67 | 2020 | |
| Mallinckrodt Enterprises LLC | $27.39 | 2019 | |
| Allergan, INC. | $26.28 | 2019-2020 | |
| Fisher & Paykel Healthcare INC | $20.47 | 2025 | Fisher & Paykel Healthcare |
| Sandoz INC. | $16.82 | 2021 | |
| Paratek Pharmaceuticals, INC. | $14.84 | 2025 | Nuzyra |
| Resmed Corp | $14.60 | 2024 | |
| La Jolla Pharmaceutical Company | $14.33 | 2022 | |
| Acacia Pharma INC | $13.61 | 2021 | |
| Eagle Pharmaceuticals, INC. | $12.30 | 2022 | |
| Merit Medical Systems INC | $4.10 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Varsha Kulkarni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.